Aarti Drugs Limited (AARTIDRUGS)
₹459.1
INR-3.10(-0.67%)
As of December 4, 2024 10:00:00 AMAarti Drugs Limited Share Price Information
24 hour Low and High
The lowest and highest prices reached in the last 24 hours of trading
Low: ₹457.3
High: ₹463
All time High
The highest price the stock has ever reached since being listed
₹1001.57
Price Change 1h
Price change in the last hour of trading
+₹1.80 +0.39%
Price Change 1d
Price change over the last trading day
+₹1.80 +0.39%
Price Change 1w
Price change over the last week of trading
+₹-10.25 +-2.18%
Aarti Drugs Limited Market Information
Exchange
The Exchange where the trading of the stock takes place
NSE
Market Cap
The current market capitalisation of the stock
4150.06 Cr
About Aarti Drugs Limited Share
Aarti Drugs Limited, through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally. The company offers aceclofenac, celecoxib, diclofenac sodium, diclodenac potassium, diclofenac diethylamine, diclofenac resinate, diclofenac epolamine, nimesulide, ciprofloxacin HCL, enrofloxacin base, gatifloxacin sesquihydrate, levofloxacin base, moxifloxacin, norfloxacin, ofloxacin, metronidazole benzoate, ornidazole, secnidazole, tinidazole, clopidogrel bisulphate, ticlopidine HCL, metformin HCL, pioglitazone HCL, teneligliptin, vildagliptin, fluconazole, ketoconazole, tolnaftate, zolpidem tartrate, niacin, raloxifene HCL, and acamprosate. It also provides benzene sulphonyl chloride, benzene sulphonic acid, benzene sulphonic acid methyl ester, sodium benzene sulfinate, para toluene sulphonyl chloride, methyl para toluenesulfonate, sodium para toluenesulfinate, para chlorobenzenesulfonyl chloride, formamide, calcium fluoride, potasium formate, benzenesulfonamide, ethyl p- toluenesulfonate, N,N',N'-tris-(4-toluene sulfonyl)-diethylenetriamine, ortho para toluene sulfonamides, ortho para toluene sulfonamides acid methyl ester, para chlorobenznesulfonamide, para toluenesulfonyl hydrazide, para toluenesulfonamide, and sodium benzenesulfonate. In addition, it offers pharma intermediate products, which includes Celecoxib, Ciprofloxacin, Clopidogrel, Diclofenac, Ketoconazole, Nimesulide, Raloxifene, Tinidazole, and Zolpidem. Further, the company develops drugs for the antioxidant, antifungal, cardiovascular, and antidiabetic therapeutic areas. The company was incorporated in 1984 and is headquartered in Mumbai, India.
Sector
Healthcare
Drug Manufacturers—Specialty & Generic
Employees
about
1064
CEO
Mr. Prakash Moreshwar Patil
Revenue (2023)
%
Country of Origin
India
Key Highlights
- Stocks to watch on September 23: Vodafone Idea, HFCL, SpiceJet, Aarti Drugs, Aster DM Healthcare
- Aarti Drugs share price rises more than 12%: To consider share buyback proposal on 26 August | Stock Market News
- Aarti Drugs Share Buyback: Stock jumps 10% as firm to repurchase shares at a 60% premium
- Aarti Drugs surges 13% as board mulls share buyback on August 26
- Aarti Drugs Buyback: All You Need To Know
Aarti Drugs Limited Resource
FAQs
The current price of Aarti Drugs Limited is INR 459.10 — it has changed by 0.39% in the past 24 hours. Watch Aarti Drugs Limited's stock price performance more closely on the chart.
Aarti Drugs Limited has a market capitalization of 41500606464 as of today.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Aarti Drugs Limited's EBITDA is INR undefined
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Aarti Drugs Limited stocks are traded under the ticker [object Object]
As of December 05, 2024, the company has 1064 employees.